Testing cord stem cell treatment for osteoarthritis safety
Treatments studied
Part of Bones, joints & muscles clinical trials.
This early study (Phase 1) checks whether an infused stem cell product made from donated umbilical cord tissue is safe in people with osteoarthritis. It’s mainly looking for side effects and whether the treatment can be given safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a diagnosis of osteoarthritis (joint wear-and-tear).
- You are willing and able to sign a written informed consent form.
- You do not currently have an active infection.
- You have no current active cancer and no history of organ transplant.
- You are not pregnant, and if you could become pregnant, you must use effective birth control.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests whether an off-the-shelf stem cell product made from donated umbilical cord tissue is safe for people with spinal cord injury. It mainly looks at side effects and safety, and may help pave the way for future effectiveness studies.
This Phase 1 trial tests how safe an intravenous (through a vein) stem cell product is for people with rheumatoid arthritis. It is mainly looking for side effects and safety rather than proving it works yet.
This early-phase study tests whether lab-made stem cells from donated umbilical cord tissue are safe for treating a skin ulcer. It mainly looks at side effects and whether the treatment can be given safely.
This early study tests whether an intravenous (through a vein) stem cell treatment made from donated umbilical cord tissue is safe for people with traumatic brain injury. It focuses mainly on side effects and safety, and only includes participants who meet several health and pregnancy-related safety checks.
This early study tests whether two types of stem cells—made from your own fat cells versus from donated umbilical-cord cells—are safe when injected into the fluid around the spinal cord. It may help researchers find safer cell-based options for people with spinal cord injury.
This early study (Phase 1) tests whether an intravenously given, donated stem cell product is safe for people with chronic kidney disease. It mainly looks at side effects and whether the treatment can be given without harming you.
Hear when a new Osteoarthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.